Hepatitis Monthly

Published by: Kowsar

Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B

Simin Dokht Shoaei 1 , Shahnaz Sali 2 , * , Mehdi Karamipour 2 and Esmail Riahi 3
Authors Information
1 Clinical Research and Development Center, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Physiology Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: February 01, 2014, 14 (2); e14228
  • Published Online: February 28, 2014
  • Article Type: Research Article
  • Received: August 19, 2013
  • Revised: November 14, 2013
  • Accepted: January 26, 2014
  • DOI: 10.5812/hepatmon.14228

To Cite: Shoaei S D, Sali S, Karamipour M, Riahi E. Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B, Hepat Mon. 2014 ;14(2):e14228. doi: 10.5812/hepatmon.14228.

Abstract
Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ma J, Jiang Y, Gong G. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection. Eur J Gastroenterol Hepatol. 2013; 25(4): 428-34[DOI][PubMed]
  • 2. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol. 2000; 15(12): 1356-61[PubMed]
  • 3. McClune AC, Tong MJ. Chronic Hepatitis B and Hepatocellular Carcinoma. Cl Liver Dis. 2010; 14(3): 461-76[DOI]
  • 4. Lai CL, Yuen MF. The Natural History and Treatment of Chronic Hepatitis B: A Critical Evaluation of Standard Treatment Criteria and End Points. Ann Internal Med. 2007; 147(1): 58-61[DOI][PubMed]
  • 5. Chen C, Yang HI, Su J, et al. RIsk of hepatocellular carcinoma across a biological gradient of serum hepatitis b virus dna level. JAMA. 2006; 295(1): 65-73[DOI][PubMed]
  • 6. Yuen MF, Yuan HJ, Wong DKH, Yuen JCH, Wong WM, Chan AOO, et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut. 2005; 54(11): 1610-4[DOI][PubMed]
  • 7. Jin W, Lin Z, Xin Y, Jiang X, Dong Q, Xuan S. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol. 2012; 12: 14[DOI][PubMed]
  • 8. EASL Jury . . EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol. 2003; 38(4): 533-40[PubMed]
  • 9. Lok AS, McMahon BJ, Practice Guidelines Committee , American Association for the Study of Liver Diseases . . Chronic hepatitis B. Hepatol. 2001; 34(6): 1225-41[DOI][PubMed]
  • 10. Piccinino F, Sagnelli E, Pasquale G, Giusti G, Battocchia A, Bernardi M, et al. Complications following percutaneous liver biopsy: A multicentre retrospective study on 68 276 biopsies. J Hepatol. 1986; 2(2): 165-73[DOI][PubMed]
  • 11. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, American Association for the Study of Liver Diseases . . Liver biopsy. Hepatol. 2009; 49(3): 1017-44[DOI][PubMed]
  • 12. Friedman LS. Controversies in liver biopsy: Who, where, when, how, why? Gastroenterol Rep. 2004; 6(1): 30-6[DOI][PubMed]
  • 13. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatol. 2003; 38(6): 1449-57[DOI][PubMed]
  • 14. Douds AC, Joseph AE, Finlayson C, Maxwell JD. Is day case liver biopsy underutilised? Gut. 1995; 37(4): 574-5[DOI][PubMed]
  • 15. Tseng PL, Wang JH, Hung CH, Tung HD, Chen TM, Huang WS, et al. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations. Kaohsiung J Med. 2013; 29(7): 385-95[PubMed]
  • 16. Zhang YX, Wu WJ, Zhang YZ, Feng YL, Zhou XX, Pan Q. Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World J Gastroenterol. 2008; 14(46): 7117-21
  • 17. Chrysanthos NV, Papatheodoridis GV, Savvas S, Kafiri G, Petraki K, Manesis EK, et al. Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis. Europ J Gastroenterol Hepatol. 2006; 18(4): 389-96[PubMed]
  • 18. Seto WK, Lee CF, Lai CL, Ip PP, Fong DY, Fung J, et al. A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B. PLoS One. 2011; 6(8)[DOI][PubMed]
  • 19. Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatol. 2005; 42(6): 1437-45[DOI][PubMed]
  • 20. Kim BK, Kim DY, Park JY, Ahn SH, Chon CY, Kim JK, et al. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int. 2010; 30(4): 546-53[DOI][PubMed]
  • 21. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981; 1(5): 431-5[DOI][PubMed]
  • 22. Desmet VJ. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435]. J hepatol. 2003; 38(4): 382-6[PubMed]
  • 23. Ishak KG, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J hepatol. 1995; 22(6): 696-9
  • 24. Fung J, Lai CL, Fong DY, Yuen JC, Wong DK, Yuen MF. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis. Liver International. 2008; 28(10): 1408-16[DOI][PubMed]
  • 25. Alavian SM, Alavian SH, Ashayeri N, Babaei M, Daneshbodi M, Hajibeigi B. Prediction of liver histological lesions with biochemical markers in chronic hepatitis B patients in Iran. Gastroenterol Hepatol. 2010; 3(2)
  • 26. Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, et al. Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int. 2006; 26(6): 666-72[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments